- The circadian clock gene Bmal1 acts as a potential anti-oncogene in pancreatic cancer by activating the p53 tumor suppressor pathwayJiang Weiliang; Zhao Senlin; Jiang Xiaohua; Zhang Erquan; Hu Guoyong; Hu Bin; Zheng Ping; Xiao Junhua; Lu Zhanjun; Lu Yingying; Ni Jianbo; Chen Congying; Wang Xingpeng; Yang Lijuan; Wan RongCancer Letters, 2016, 371(2): 314-325.
- The MiR-135b-BMAL1-YY1 loop disturbs pancreatic clockwork to promote tumourigenesis and chemoresistanceJiang Weiliang; Zhao Senlin; Shen Jia; Guo Lihong; Sun Yi; Zhu Yuntian; Ma Zhixiong; Zhang Xin; Hu Yangyang; Xiao Wenqin; Li Kai; Li Sisi; Zhou Li; Huang Li; Lu Zhanjun; Feng Yun; Xiao Junhua; Zhang Eric Erquan; Yang Lijuan; Wan RongCELL DEATH & DISEASE, 2018, 9: 149.
- DEC1 and DEC2 Crosstalk between Circadian Rhythm and Tumor ProgressionSato Fuyuki; Bhawal Ujjal K; Yoshimura Tomohiro; Muragaki YasuteruJournal of Cancer, 2016, 7(2): 153-159.
期刊论文
Decreased circadian component Bmal1 predicts tumor progression and poor prognosis in human pancreatic ductal adenocarcinoma
9阅读
